You are here

gastric cancer

Pfizer, Merck KGaA run into a severe setback as PD-L1 drug Bavencio fails in PhIII gastric cancer study

Endpoints

Tue, 11/28/17 - 10:11 am

Billionaire-backed Ganymed grabs ASCO spotlight with gastric cancer drug

Fierce Biotech

Sun, 06/5/16 - 12:05 pm

ImmunoGen, Roche gastric cancer drug fails study

Yahoo/Reuters

Thu, 10/22/15 - 09:54 am

clinical trials

Gilead: No Big Deals

Barron's

Wed, 05/13/15 - 05:00 pm

Gilead Sciences

MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at

Yahoo/BusinessWire

Sun, 09/28/14 - 10:10 am

Lilly's Cyramza shows survival benefit in gastro cancers

Pharma Times

Fri, 09/19/14 - 09:53 am

Genentech granted FDA orphan status for gastric cancer treatment

Yahoo/Fly on the Wall

Fri, 05/2/14 - 09:53 am

cancer of the gastro-esophageal junction

Lilly’s Gastric Cancer Drug Wins Approval From U.S. FDA

Bloomberg

Mon, 04/21/14 - 04:58 pm

FDA Grants Lilly's Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer

Marketwatch

Thu, 10/24/13 - 10:29 am

Eli Lilly's ramucirumab for gastric cancer shows positive Phase III results

Yahoo/Fly on the Wall

Thu, 10/3/13 - 09:09 am

Lilly drug fails in breast cancer, succeeds in gastric cancer

Reuters

Thu, 09/26/13 - 08:14 am

Merrimack Progresses with MM-111

Yahoo/Zacks

Sat, 07/27/13 - 11:13 am

Merrimack Pharmaceuticals

esophageal cancer

gastroesophageal cancer

Merrimack initiates Phase 2 clinical study of MM-111

Yahoo/Fly on the Wall

Mon, 07/22/13 - 11:26 am

Merrimack Pharmaceuticals

Glaxo Reports Disappointing Tykerb Data

Yahoo/Zacks

Mon, 06/10/13 - 08:05 pm

Eli Lilly drops after cancer drug data seen as 'underwhelming'

The Fly on the Wall

Wed, 01/23/13 - 10:43 am

Lilly's gastric cancer drug meets late-stage goal

Reuters

Mon, 10/15/12 - 10:41 am

Amgen Revives Defunct Drug as Old Therapies Seek New Cure

Bloomberg

Thu, 05/17/12 - 10:30 am

Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab

Pipeline Review

Sun, 03/25/12 - 12:39 pm

Synthon Pharmaceuticals

Array BioPharma Announces Positive Interim Results for Phase 1 Study of Its HER2 Inhibitor, ARRY-380, in Cancer Patients

Earth Times

Sun, 12/13/09 - 12:10 pm

Array Biopharma

Pages